Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.73% | $13.60M | €435.69B | 66.23% | 76 Outperform | |
| Roche Holding AG | 1.60% | $7.96M | CHF287.79B | 43.00% | 73 Outperform | |
| HSBC Holdings | 1.53% | $7.64M | £224.58B | 58.21% | 80 Outperform | |
| AstraZeneca | 1.47% | $7.31M | £213.91B | 24.00% | 80 Outperform | |
| Novartis AG | 1.43% | $7.14M | CHF225.91B | 20.41% | 80 Outperform | |
| Nestlé SA | 1.26% | $6.30M | CHF197.51B | 16.11% | 71 Outperform | |
| Siemens | 1.17% | $5.83M | €188.82B | 24.62% | 74 Outperform | |
| Toyota Motor | 1.09% | $5.45M | ¥48.55T | 28.76% | 80 Outperform | |
| Mitsubishi UFJ Financial Group | 1.06% | $5.28M | ¥32.98T | 41.02% | 76 Outperform | |
| SAP SE | 1.03% | $5.13M | €190.37B | -38.27% | 66 Neutral |